Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

When standard genetic testing does not solve the mystery: a rare case of preimplantation genetic diagnosis for campomelic dysplasia in the setting of parental mosaicism.

Patel B, Byrne JLB, Phillips A, Hotaling JM, Johnstone EB.

Fertil Steril. 2018 Sep;110(4):732-736. doi: 10.1016/j.fertnstert.2018.05.002.

PMID:
30196970
2.

Defining metabolically healthy obesity in children: a scoping review.

Damanhoury S, Newton AS, Rashid M, Hartling L, Byrne JLS, Ball GDC.

Obes Rev. 2018 Nov;19(11):1476-1491. doi: 10.1111/obr.12721. Epub 2018 Aug 28.

PMID:
30156016
3.

Germline but not somatic de novo mutations are common in human congenital diaphragmatic hernia.

Matsunami N, Shanmugam H, Baird L, Stevens J, Byrne JL, Barnhart DC, Rau C, Feldkamp ML, Yoder BA, Leppert MF, Yost HJ, Brunelli L.

Birth Defects Res. 2018 Apr 17;110(7):610-617. doi: 10.1002/bdr2.1223. Epub 2018 Mar 23.

PMID:
29570242
4.

De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial.

Clark RE, Polydoros F, Apperley JF, Milojkovic D, Pocock C, Smith G, Byrne JL, de Lavallade H, O'Brien SG, Coffey T, Foroni L, Copland M.

Lancet Haematol. 2017 Jul;4(7):e310-e316. doi: 10.1016/S2352-3026(17)30066-2. Epub 2017 May 26.

5.

Etiology and clinical presentation of birth defects: population based study.

Feldkamp ML, Carey JC, Byrne JLB, Krikov S, Botto LD.

BMJ. 2017 May 30;357:j2249. doi: 10.1136/bmj.j2249.

6.

Following Suit: Using Conversation Cards for Priority Setting in Pediatric Weight Management.

Kebbe M, Byrne JLS, Damanhoury S, Ball GDC.

J Nutr Educ Behav. 2017 Jul - Aug;49(7):588-592.e1. doi: 10.1016/j.jneb.2017.03.020. Epub 2017 May 3.

PMID:
28479009
7.

Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Onida F, de Wreede LC, van Biezen A, Eikema DJ, Byrne JL, Iori AP, Schots R, Jungova A, Schetelig J, Finke J, Veelken H, Johansson JE, Craddock C, Stelljes M, Theobald M, Holler E, Schanz U, Schaap N, Bittenbring J, Olavarria E, Chalandon Y, Kröger N.

Br J Haematol. 2017 Jun;177(5):759-765. doi: 10.1111/bjh.14619. Epub 2017 Mar 28.

PMID:
28369779
8.

Registration status and methodological reporting of randomized controlled trials in obesity research: A review.

Byrne JL, Yee T, O'Connor K, Dyson MP, Ball GD.

Obesity (Silver Spring). 2017 Apr;25(4):665-670. doi: 10.1002/oby.21784. Epub 2017 Mar 11. Review.

9.

Deficiencies in postgraduate training for healthcare professionals who provide diabetes education and support: results from the Diabetes Attitudes, Wishes and Needs (DAWN2) study.

Byrne JL, Davies MJ, Willaing I, Holt RIG, Carey ME, Daly H, Skovlund S, Peyrot M.

Diabet Med. 2017 Aug;34(8):1074-1083. doi: 10.1111/dme.13334. Epub 2017 Mar 9.

PMID:
28195662
10.

A brief eHealth tool delivered in primary care to help parents prevent childhood obesity: a randomized controlled trial.

Byrne JL, Cameron Wild T, Maximova K, Browne NE, Holt NL, Cave AJ, Martz P, Ellendt C, Ball GD.

Pediatr Obes. 2016 Nov 10. doi: 10.1111/ijpo.12200. [Epub ahead of print]

PMID:
27863165
11.

Clinical presentation and survival in a population-based cohort of infants with gastroschisis in Utah, 1997-2011.

Feldkamp ML, Botto LD, Byrne JLB, Krikov S, Carey JC.

Am J Med Genet A. 2016 Feb;170A(2):306-315. doi: 10.1002/ajmg.a.37437. Epub 2015 Oct 16.

PMID:
26473400
12.

Chlamydia trachomatis IgG3 seropositivity is associated with gastroschisis.

Feldkamp ML, Enioutina EY, Botto LD, Krikov S, Byrne JL, Geisler WM.

J Perinatol. 2015 Nov;35(11):930-4. doi: 10.1038/jp.2015.115. Epub 2015 Sep 17.

13.

Risk factors for Dandy-Walker malformation: a population-based assessment.

Reeder MR, Botto LD, Keppler-Noreuil KM, Carey JC, Byrne JL, Feldkamp ML; National Birth Defects Prevention Study.

Am J Med Genet A. 2015 Sep;167A(9):2009-16. doi: 10.1002/ajmg.a.37124. Epub 2015 May 1.

PMID:
25941000
14.

Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation.

Shaw BE, Lee F, Krishnamurthy S, Byrne JL, Seedhouse C, Mayor NP, Maldonado-Torres H, Saudemont A, Marsh SG, Madrigal JA, Russell NH.

Bone Marrow Transplant. 2015 Feb;50(2):237-43. doi: 10.1038/bmt.2014.238. Epub 2014 Oct 27.

PMID:
25347010
15.

Velamentous cord insertion with variable umbilical cord Doppler changes.

Bowman ZS, Byrne JL, Kennedy AM.

J Ultrasound Med. 2014 Nov;33(11):2039-41. doi: 10.7863/ultra.33.11.2039. No abstract available.

PMID:
25336494
16.

Admission to a dedicated cardiac intensive care unit is associated with decreased resource use for infants with prenatally diagnosed congenital heart disease.

Johnson JT, Tani LY, Puchalski MD, Bardsley TR, Byrne JL, Minich LL, Pinto NM.

Pediatr Cardiol. 2014 Dec;35(8):1370-8. doi: 10.1007/s00246-014-0939-x. Epub 2014 Jun 4.

PMID:
24894897
17.

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.

Fox CP, Burns D, Parker AN, Peggs KS, Harvey CM, Natarajan S, Marks DI, Jackson B, Chakupurakal G, Dennis M, Lim Z, Cook G, Carpenter B, Pettitt AR, Mathew S, Connelly-Smith L, Yin JA, Viskaduraki M, Chakraverty R, Orchard K, Shaw BE, Byrne JL, Brookes C, Craddock CF, Chaganti S.

Bone Marrow Transplant. 2014 Feb;49(2):280-6. doi: 10.1038/bmt.2013.170. Epub 2013 Nov 11.

PMID:
24212561
18.

EBV-driven relapse of peripheral T-cell lymphoma, masquerading as a post transplant lymphoproliferative disorder following allo-SCT.

Fox CP, Bishton MJ, O'Connor S, Hughes S, Byrne JL, Russell N.

Bone Marrow Transplant. 2014 Jan;49(1):150-2. doi: 10.1038/bmt.2013.125. Epub 2013 Aug 12. No abstract available.

PMID:
23933761
19.

Pepperpot or not?

Harvey CM, Gallagher RG, Fairbairn KJ, Byrne JL.

Br J Haematol. 2013 Aug;162(4):431. doi: 10.1111/bjh.12426. Epub 2013 Jun 15. No abstract available.

PMID:
23772893
20.

A family-based paradigm to identify candidate chromosomal regions for isolated congenital diaphragmatic hernia.

Arrington CB, Bleyl SB, Matsunami N, Bowles NE, Leppert TI, Demarest BL, Osborne K, Yoder BA, Byrne JL, Schiffman JD, Null DM, DiGeronimo R, Rollins M, Faix R, Comstock J, Camp NJ, Leppert MF, Yost HJ, Brunelli L.

Am J Med Genet A. 2012 Dec;158A(12):3137-47. doi: 10.1002/ajmg.a.35664. Epub 2012 Nov 19.

21.

Identification of a prenatal profile of Cornelia de Lange syndrome (CdLS): a review of 53 CdLS pregnancies.

Clark DM, Sherer I, Deardorff MA, Byrne JL, Loomes KM, Nowaczyk MJ, Jackson LG, Krantz ID.

Am J Med Genet A. 2012 Aug;158A(8):1848-56. doi: 10.1002/ajmg.a.35410. Epub 2012 Jun 27. Review.

22.

An automated process for calculating long bone deviations in fetuses with suspected skeletal dysplasia.

Winter TC, Kennedy AM, Byrne JL, Woodward PJ.

J Ultrasound Med. 2012 Jul;31(7):1140-1. No abstract available.

PMID:
22733864
23.

Germline mosaicism in Cornelia de Lange syndrome.

Slavin TP, Lazebnik N, Clark DM, Vengoechea J, Cohen L, Kaur M, Konczal L, Crowe CA, Corteville JE, Nowaczyk MJ, Byrne JL, Jackson LG, Krantz ID.

Am J Med Genet A. 2012 Jun;158A(6):1481-5. doi: 10.1002/ajmg.a.35381. Epub 2012 May 11.

24.

Analysis of skeletal dysplasias in the Utah population.

Stevenson DA, Carey JC, Byrne JL, Srisukhumbowornchai S, Feldkamp ML.

Am J Med Genet A. 2012 May;158A(5):1046-54. doi: 10.1002/ajmg.a.35327. Epub 2012 Mar 27.

PMID:
22461456
25.

Survey of physicians' approach to severe fetal anomalies.

Heuser CC, Eller AG, Byrne JL.

J Med Ethics. 2012 Jul;38(7):391-5. doi: 10.1136/medethics-2011-100340. Epub 2012 Jan 19.

PMID:
22267341
26.
27.

Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation.

Morgan GJ, Davies FE, Gregory WM, Russell NH, Bell SE, Szubert AJ, Navarro Coy N, Cook G, Feyler S, Byrne JL, Roddie H, Rudin C, Drayson MT, Owen RG, Ross FM, Jackson GH, Child JA; NCRI Haematological Oncology Study Group.

Blood. 2011 Aug 4;118(5):1231-8. doi: 10.1182/blood-2011-02-338665. Epub 2011 Jun 7.

28.

Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.

Shaw BE, Apperley JF, Russell NH, Craddock C, Liakopoulou E, Potter MN, Wynn R, Gibson B, Pearce RM, Kirkland K, Lee J, Madrigal JA, Cook G, Byrne JL.

Br J Haematol. 2011 Apr;153(2):244-52. doi: 10.1111/j.1365-2141.2011.08615.x. Epub 2011 Mar 8.

PMID:
21382020
29.

Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission.

Bokhari SW, Munir T, Memon S, Byrne JL, Russell NH, Beed M.

Ann Hematol. 2010 May;89(5):505-12. doi: 10.1007/s00277-009-0853-0. Epub 2009 Oct 30.

PMID:
19876629
30.

Group A streptococcal puerperal sepsis: initial characterization of virulence factors in association with clinical parameters.

Byrne JL, Aagaard-Tillery KM, Johnson JL, Wright LJ, Silver RM.

J Reprod Immunol. 2009 Oct;82(1):74-83. doi: 10.1016/j.jri.2009.06.126. Epub 2009 Aug 13.

PMID:
19682751
31.

Reliability of fetal middle cerebral artery velocity measurements: a randomized controlled trial of sonographer training.

Clark EA, Lacoursiere DY, Byrne JL, Ponder R, Silver RM, Esplin MS.

J Ultrasound Med. 2009 Jan;28(1):19-25. Erratum in: J Ultrasound Med. 2009 May;28(5):706.

PMID:
19106352
32.

Clinical considerations in gastroschisis: incremental advances against a congenital anomaly with severe secondary effects.

Nichol PF, Byrne JL, Dodgion C, Saijoh Y.

Am J Med Genet C Semin Med Genet. 2008 Aug 15;148C(3):231-40. doi: 10.1002/ajmg.c.30180.

PMID:
18655104
33.

Autosomal recessive hypophosphatasia manifesting in utero with long bone deformity but showing spontaneous postnatal improvement.

Stevenson DA, Carey JC, Coburn SP, Ericson KL, Byrne JL, Mumm S, Whyte MP.

J Clin Endocrinol Metab. 2008 Sep;93(9):3443-8. doi: 10.1210/jc.2008-0318. Epub 2008 Jun 17.

34.

Unilateral short femur--what does this mean? Report of 3 cases.

Oh KY, Frias AE Jr, Byrne JL, Kennedy AM.

Ultrasound Q. 2008 Jun;24(2):89-92. doi: 10.1097/RUQ.0b013e31817d456c.

PMID:
18528244
35.

Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia.

Tholouli E, Liakopoulou E, Greenfield HM, Shaw BE, Tauro S, Byrne JL, Dennis M, Burthem J, Lucas GS, Craddock C, Russell NH, Liu Yin JA.

Br J Haematol. 2008 Jun;142(2):318-20. doi: 10.1111/j.1365-2141.2008.07184.x. Epub 2008 May 19. No abstract available.

PMID:
18492100
36.

Seven-week embryo with gastroschisis, multiple anomalies, and physiologic hernia suggests early onset of gastroschisis.

Byrne JL, Feldkamp ML.

Birth Defects Res A Clin Mol Teratol. 2008 Apr;82(4):236-8. doi: 10.1002/bdra.20446.

PMID:
18338390
37.

Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.

Ingram W, Devereux S, Das-Gupta EP, Russell NH, Haynes AP, Byrne JL, Shaw BE, McMillan A, Gonzalez J, Ho A, Mufti GJ, Pagliuca A.

Br J Haematol. 2008 Apr;141(2):235-43. doi: 10.1111/j.1365-2141.2008.07067.x. Epub 2008 Mar 3.

PMID:
18318762
38.

Brachymesomelic dysplasia with Peters anomaly of the eye results from disruptions of the X chromosome near the SHOX and SOX3 genes.

Bleyl SB, Byrne JL, South ST, Dries DC, Stevenson DA, Rope AF, Vianna-Morgante AM, Schoenwolf GC, Kivlin JD, Brothman A, Carey JC.

Am J Med Genet A. 2007 Dec 1;143A(23):2785-95.

PMID:
17994562
39.

Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia.

Olavarria E, Siddique S, Griffiths MJ, Avery S, Byrne JL, Piper KP, Lennard AL, Pallan L, Arrazi JM, Perz JB, O'Shea D, Goldman JM, Apperley JF, Craddock CF.

Blood. 2007 Dec 15;110(13):4614-7. Epub 2007 Sep 19.

40.

Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab.

Das-Gupta EP, Russell NH, Shaw BE, Pearce RM, Byrne JL.

Biol Blood Marrow Transplant. 2007 Jun;13(6):724-33.

41.

The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants.

Shaw BE, Byrne JL, Das-Gupta E, Carter GI, Russell NH.

Biol Blood Marrow Transplant. 2007 May;13(5):550-9. Epub 2007 Feb 15.

42.
43.

Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak.

Shaw BE, Boswell T, Byrne JL, Yates C, Russell NH.

Bone Marrow Transplant. 2007 May;39(10):623-9. Epub 2007 Mar 26.

PMID:
17384657
44.

High dose melphalan or intermediate dose melphalan can be well tolerated and result in good response rates in selected elderly patients with myeloma.

Bishton M, Gilyead M, Das Gupta E, Williams C, Russell NH, Byrne JL.

Leuk Res. 2007 Aug;31(8):1063-8. Epub 2007 Feb 26.

PMID:
17324463
46.

Mortality and pathological findings in C (Opitz trigonocephaly) syndrome.

Opitz JM, Putnam AR, Comstock JM, Chin S, Byrne JL, Kennedy A, Frikke MJ, Bernard C, Albrecht S, Der Kaloustian V, Szakacs JG.

Fetal Pediatr Pathol. 2006 Jul-Aug;25(4):211-31. Review.

PMID:
17162528
47.

Stillbirth at term.

Eller AG, Branch DW, Byrne JL.

Obstet Gynecol. 2006 Aug;108(2):442-7. No abstract available.

PMID:
16880318
48.
49.

A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation.

Sirohi B, Powles RL, Chopra R, Russell N, Byrne JL, Prentice HG, Potter M, Koblinger S.

Bone Marrow Transplant. 2006 Jul;38(1):47-51. Epub 2006 May 22.

PMID:
16715107
50.

Low dose erythropoietin is effective in reducing transfusion requirements following allogeneic HSCT.

Fox CP, Pacey S, Das-Gupta EP, Russell NH, Byrne JL.

Transfus Med. 2005 Dec;15(6):475-80.

PMID:
16359418

Supplemental Content

Loading ...
Support Center